Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
AMIVANTAMAB 2 240 MG-HYALURONIDASE-LPUJ 28 000 UNIT/14 ML SUBCUT SOLN (CDM RX-196201) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 24, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-196201/by-state?code_type=CDM
“AMIVANTAMAB 2 240 MG-HYALURONIDASE-LPUJ 28 000 UNIT/14 ML SUBCUT SOLN (CDM RX-196201) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-196201/by-state?code_type=CDM. Accessed
October 24, 2026 .
“AMIVANTAMAB 2 240 MG-HYALURONIDASE-LPUJ 28 000 UNIT/14 ML SUBCUT SOLN (CDM RX-196201) by State,” HANK Price Transparency ,
accessed October 24, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-196201/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-196201 — Amivantamab 2 240 Mg-hyaluronidase-lpuj 28 000 Unit/14 Ml Subcut Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$48,541
National median
$42,473 – $60,676
IQR (p25 – p75)
3
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$60,676
vs. negotiated
+25.0%
Hospitals reporting
3
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-196201 (CDM), with interquartile range
State Median p25 p75
AL $48,541 $42,473 $60,676